NUVATION BIO NUVB 深 沪
等待开盘 04-01 09:30:00 美东时间
4.29
+0.240
+5.93%
华盛通- 最 高4.30
- 今 开4.17
- 成交量 423.42万股
- 最 低 4.12
- 昨 收 4.05
- 总市值 14.91亿
- 52周最高 9.75
- 市盈率 静 --
- 换手率 1.22%
- 52周最低 1.57
- 委 比 -1.70%
- 总股本 3.48亿
- 历史最高 15.23
- 量 比 1.37
- 振 幅 4.44%
- 历史最低 0.95
- 每 手 1
- 风险率 2.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 能源股再或大行青睐！康菲石油、雪铁龙、埃克森美孚、响尾蛇能源等获上调目标价；Unity评级分歧大，大摩、美银上调，富国银行下调
今日重点评级关注：花旗：维持Biomea Fusion"买入"评级，目标价从6美元升至7美元；Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.75美元升至8.25美元
03-30 11:49
Eisai, Nuvation Bio Announces European Medicines Agency Validate Marketing Authorisation Application For Taletrectinib To Treat ROS1-Positive Non-Small Cell Lung Cancer
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a human-centered global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas, and Nuvation Bio Inc.
03-27 04:25
Nuvation Bio Reports IBTROZI Achieves 50-Month Median Response In ROS1+ NSCLC, To Be Presented At AACR 2026
Clinical data demonstrate IBTROZI's unprecedented durability in TKI-naïve advanced ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC), with median Duration of Response (DOR) now increased to 50 months as of August
03-18 04:35
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Deep Dive Into Nuvation Bio Stock: Analyst Perspectives (7 Ratings)
7 analysts have shared their evaluations of Nuvation Bio (NYSE:NUVB) during the...
03-04 05:00
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Edesa Biotech (NASDAQ:EDSA) shares rose 61.0% to $3.67 during Tuesday'...
03-04 01:05
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $13
RBC Capital analyst Leonid Timashev maintains Nuvation Bio (NYSE:NUVB) with a Outperform and raises the price target from $12 to $13.
03-03 23:43
Why Ouster Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quar
03-03 18:27
财报速睇 | NUVATION BIO 2025财年年度营收0.63亿美元，同比增长699.0%；归母净利润亏损2.05亿美元，同比亏损缩窄64.0%
华盛资讯3月3日讯，NUVATION BIO公布2025财年年度业绩，公司年度营收0.63亿美元，同比增长699.0%，归母净利润亏损2.05亿美元，同比亏损缩窄64.0%。
03-03 07:47
财报速睇 | NUVATION BIO 2025财年Q4营收0.42亿美元，同比增长600.0%；归母净利润亏损0.37亿美元，同比亏损缩窄24.5%
华盛资讯3月3日讯，NUVATION BIO公布2025财年Q4业绩，公司Q4营收0.42亿美元，同比增长600.0%，归母净利润亏损0.37亿美元，同比亏损缩窄24.5%。
03-03 07:05
